Product Wiki · Recalls · U.S. FDA — Food Enforcement

a2 Platinum Premium infant formula Milk-based Powder with Iron 31.7oz… — recall H-0891-2026

U.S. FDA — Food Enforcement · United States · 2026-05-01 · Class I

As described by U.S. FDA — Food Enforcement: a2 Platinum Premium infant formula Milk-based Powder with Iron 31.7oz (900g) Intended use: infant formula (0 12 months). Condition: shelf stable product Type of packaging: metal tin with plastic dust cap. Net weight: 31.7oz (900gm). UPC: 813267020335. Firm name listed on label: The a2 Milk Company

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
U.S. FDA — Food Enforcement
Recall identifier
H-0891-2026
Date of alert
2026-05-01
Country / jurisdiction
United States
Risk level
Class I
Notice type
recall
Brand
The a2 Milk Company
Product category
food
Product type
Food
Recall status
Terminated — the recall action is complete and the FDA has closed it
Initiated by
Voluntary: Firm initiated
Distribution
The recalled product was distributed throughout the United States.
Reported risk: Possible contamination with Cereulide toxin.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from U.S. FDA — Food Enforcement →

Primary source: https://api.fda.gov/food/enforcement.json?search=recall_number:%22H-0891-2026%22

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.